Trials / Recruiting
RecruitingNCT06414928
Prognostic Model Heart Failure
In-hospital & 30-day Prognostication of Acute Heart Failure Patients by Comparing 4 Validated Scores in Patients Presenting to the Emergency Department of Cardiac Tertiary Care Hospital, Karachi- Pakistan
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- National Institute of Cardiovascular Diseases, Pakistan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to determine the prognosis of heart failure in our population by using multiple validated risk scores and to evaluate the strengths of these scores in assessing prognosis with better discrimination.
Detailed description
After fulfilling the eligibility criteria, informed consent will be obtained from all the patients regarding using data for research while maintaining anonymity. All the included patients will be interviewed by the assigned physician to complete the detailed questionnaire, including patient demographics, risk factors, and validated questionnaires including the Acute Decompensated Heart Failure National Registry (ADHERE), The Get With The Guideline-Heart Failure (GWTG-HF) Risk Score, the Ottawa Heart Failure Risk Scale (OHFRS), and EHMRG30-ST score. All the patients will be followed after 30 days, and survival status will be obtained. The AUC of the GWTG-HF risk score for all-cause death was 0.687 (95% CI, 0.649-0.725) \[18\], at 95% confidence interval, ±3% margin of error, the sample size was calculated to be n=626 patients. The calculated sample size was inflated by a factor of 1.5 for the design effect; hence, the sample size for the study will be N=939. For data verification, 10% of the data will be cross-checked with the source document (Patient file).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Acute Heart Failure | Consecutive patients presented at Emergency Departement with Acute Heart Failure |
Timeline
- Start date
- 2024-02-14
- Primary completion
- 2026-02-14
- Completion
- 2026-06-14
- First posted
- 2024-05-16
- Last updated
- 2024-05-16
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06414928. Inclusion in this directory is not an endorsement.